13:05 IST
BSE
Annual Report
Bacil Pharma Annual Report
Bacil Pharma Limited submitted its 39th Annual Report for FY 2025-26. The Annual General Meeting is scheduled for September 23, 2026, via video conferencing.
Bacil Pharma Ltd
- Share price
- ₹25.50
- Market cap
- ₹36.60 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹1.56 Cr
- P/E (TTM)
- 55.8×Sector 47.4×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Board Meeting Date 2Financial Results 1Board Meeting Outcome 1Annual Report 1Annual General Meeting 1
Time
6 announcements with these filters
13:25 IST
BSE
Annual General Meeting
Bacil Pharma Annual General Meeting
Bacil Pharma Limited has announced book closure dates from September 17 to September 23, 2026, for its 39th Annual General Meeting.
18:42 IST
BSE
Board Meeting Date
Bacil Pharma Board Meeting Date
Bacil Pharma Limited has scheduled a board meeting for August 29, 2026, to discuss and approve the notice and scheduling of its 39th Annual General Meeting.
16:50 IST
BSE
Board Meeting Outcome
Bacil Pharma Board Meeting Outcome
Bacil Pharma Limited announced the appointment of Mr. Mahesh Singh and Mr. Anil Shiv Charan Singh as Additional Directors following its board meeting.
22:54 IST
BSE
Board Meeting Date
Bacil Pharma Board Meeting Date
Bacil Pharma Ltd has scheduled a Board Meeting for August 25, 2026. The agenda includes the discussion on the appointment of directors.
16:14 IST
BSE
Financial Results
Bacil Pharma Q1 FY27 Results: Net Profit ₹0.3 Cr, Down 57.1% YoY
Bacil Pharma Ltd reported net profit of ₹0.3 Cr (-57.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.3 Cr · -57.1% YoY